Dr. Lindsay Rosenwald

Dr Lindsay Rosenwald, Biography.

Wall Street Transcript Interview (2018) IDB Bank Profile Biography (2011) LR Facts*, below. For...
biotech stock review

Orchestra BioMed™ Announces Completion of $41 Million Financing.

November 15, 2018 Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and...

Immunomedics Chairman Buys $19 Million More in Stock.

(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132,...
Steven Boyd, Armistice

Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).

A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied...

Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage...
Biotech Stock Review, Dicerna DRNA

Adding Dicerna (DRNA) $3.30 to Watch List.

Adding Dicerna (DRNA) $3.30 to Watch List. How fun would it be to sell a $3.00 idea (IMMU) at...
Biotech Stock Review

Adding Immunomedics (IMMU) $3.00 to Watch List.

Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.

Latest article

Immunomedics, Biotech Stock Review

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.

Our First Newsletter of 2020, We Come out Swinging! Yes, you read it right. Five of our favorite...
Citius Pharmaceutical, CTXR, Biotech Stock Review

Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...
Oramed, Biotech Stock REview

Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?

New technology could revolutionize market of 500 million diabetes patients (i24 News).